<DOC>
	<DOCNO>NCT02944591</DOCNO>
	<brief_summary>The purpose research study investigate potential benefit participant use smartphone application ( `` App '' ) call COPD Co-Pilot™ . When used participant , COPD Co-Pilot™ may provide early detection worsen COPD symptom . Early symptom detection may allow pulmonary provider nurse respond timely medical advice treatment . The goal use COPD Co-Pilot™ reduce frequency duration hospitalization , emergency department visit , hospital readmission . The study also examine financial impact COPD Co-Pilot™ program determine whether cost hospital stay , emergency department visit , hospital readmission differ patient enrol COPD Co-Pilot™ enrol . Another purpose study measure patient satisfaction use COPD Co-Pilot™ .</brief_summary>
	<brief_title>Evaluation COPD Co-Pilot</brief_title>
	<detailed_description>During 6-month observational period , subject report respiratory symptom use COPD Co-Pilot daily basis receive feedback clinical recommendation health care provider symptom change baseline symptom . Final clinical recommendation , medical advice , diagnose , treatment full sole discretion provider . All subject receive current standard care supervision health care provider . No experimental drug , dosage , treatment protocol administer stage trial . Subjects receive monthly call determine whether change subject 's medical history , hospitalization history , medication , etc . occur may add subject 's profile . At approximately 6 month post enrollment , subject person end study visit .</detailed_description>
	<mesh_term>Lung Diseases</mesh_term>
	<mesh_term>Chronic Disease</mesh_term>
	<mesh_term>Pulmonary Disease , Chronic Obstructive</mesh_term>
	<criteria>1 . Subject read , understood sign informed consent form prior enrollment . 2 . Males females age ≥35 year old 3 . Documented diagnosis moderate severe COPD ( GOLD Level IIIV ) 4 . Must able read understand English consent 5 . Subject willing able use iPad mini device . 1 . Subject acute exacerbation COPD require hospitalization ER visit treatment systemic steroid and/or antibiotic 28 day prior enrollment . • Subjects COPD exacerbation within 28 day prior Visit 1 rescreened . Rescreening occur earlier 28 day last dose systemic steroid and/or antibiotic and/or hospitalization , whichever later 2 . Subject COPD exacerbation respiratory illness RunIn period judgment investigator require medical intervention ( e.g. , treatment systemic steroid and/or antibiotic and/or hospitalization ) . • Subjects COPD exacerbation infection RunIn period rescreened . Rescreening occur earlier 28 day last dose systemic steroid and/or antibiotic and/or hospitalization , whichever later . 3 . Subject suffer terminal illness expect adversely affect survival next 12 month 4 . Subject history noncompliance medical therapy 5 . Subject cognitive impairment ( determined physician ) make hard follow instruction regard device usage 6 . Subject currently know suffer history significant substance abuse within last 2 year 7 . Subject condition opinion provider may adversely affect participation 8 . Subject reside hospice care , Skilled Nursing Facilities Long Term Acute Care facility 9 . Subject plan procedure time enrollment occur within timeframe study require hospitalization otherwise adversely affect ability participate 10 . Subject may , opinion provider , noncompliant study schedule procedures 11 . Subject cellular coverage primary residence 12 . Subject plan travel location cellular coverage significant period ( &gt; 1 week ) program participation</criteria>
	<gender>All</gender>
	<minimum_age>35 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2016</verification_date>
</DOC>